• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Centene Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    3/5/25 4:53:41 PM ET
    $CNC
    Medical Specialities
    Health Care
    Get the next $CNC alert in real time by email
    cnc-20250305
    0001071739false00010717392025-03-052025-03-05



    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): March 5, 2025

    CENTENE CORPORATION
    (Exact Name of Registrant as Specified in Charter)

    Delaware001-3182642-1406317
    (State or Other Jurisdiction
    of Incorporation)
    (Commission File Number)
    (IRS Employer
    Identification No.)
    7700 Forsyth Boulevard,
    St. Louis,Missouri63105
    (Address of Principal Executive Offices)(Zip Code)
    Registrant’s telephone number, including area code: (314) 725-4477
    (Former Name or Former Address, if Changed Since Last Report): N/A
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common stock, $0.001 Par Value
    CNC
    New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
     
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





    ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

    On March 5, 2025 (the Effective Date), Centene Corporation, a Delaware corporation (Centene), entered into a new Credit Agreement (the New Credit Agreement) by and among Centene, the lenders from time to time party thereto and Wells Fargo Bank, National Association (Wells Fargo), as the administrative agent for the lenders, and, substantially contemporaneously therewith, Centene terminated all outstanding commitments and repaid all outstanding obligations under that certain Fourth Amended and Restated Credit Agreement, dated as of August 16, 2021 (as amended, supplemented or modified prior to the Effective Date, the Existing Credit Agreement), by and among Centene, the several banks and other financial institutions party thereto, and Wells Fargo, as the administrative agent.

    The New Credit Agreement provides for (i) a revolving credit facility in the principal amount of $4,000,000,000 (the Revolving Credit Facility) and (ii) a term loan facility in the principal amount of $2,000,000,000 (the Term Loan Facility and, together with the Revolving Credit Facility, the Senior Unsecured Credit Facility). The maturity date for the Senior Unsecured Credit Facility is March 5, 2030. Loans under the Revolving Credit Facility may be denominated in U.S. dollars, Euros, Sterling, Swiss Francs, Yen, Australian dollars and Canadian dollars and each other currency which has been approved under the terms of the New Credit Agreement.

    Borrowings under the Senior Unsecured Credit Facility will bear interest at a fluctuating rate per annum equal to a benchmark rate applicable to the currency composing such borrowing plus an applicable margin. The applicable margin is in each case based on the rating of Centene’s corporate debt obligations by S&P and Moody’s.

    The New Credit Agreement contains affirmative and negative covenants customary for unsecured credit facilities of this nature, including, among others, limitations on Centene and its subsidiaries with respect to liens, the incurrence of indebtedness by subsidiaries of Centene, and certain fundamental changes. The New Credit Agreement contains representations and warranties customary for unsecured credit facilities of this nature. As of the Effective Date, there are no subsidiary guarantors under the Senior Unsecured Credit Facility.

    Centene is subject to a financial covenant under the New Credit Agreement, tested quarterly, whereby the debt-to-capital ratio may not exceed 0.60 to 1.00, with a step-up, upon Centene’s election, following the consummation of a material acquisition, to 0.65 to 1.00 during certain specified periods.

    Centene made a single drawing under the Term Loan Facility on the Effective Date and the proceeds thereof were used for, among other things, to (i) refinance existing indebtedness, including under the Existing Credit Agreement, (ii) pay fees, commissions and expenses in connection with the transactions described herein and (iii) for working capital and other general corporate purposes.

    Voluntary prepayments of the loans and voluntary reductions of the unutilized portion of the commitments under the Senior Unsecured Credit Facility are permissible, in each case, without penalty, subject to certain conditions pertaining to minimum notice and minimum reduction amounts as described in the New Credit Agreement.

    The New Credit Agreement is subject to acceleration upon the occurrence of an event of default, which includes, among other things, cross-default with regard to indebtedness of Centene or its significant subsidiaries in excess of $500 million in the aggregate; the occurrence of a change in control (as defined in the New Credit Agreement); entry of judgment or order to pay $500 million or more which is not stayed or paid; the occurrence of certain bankruptcy events; failure to make payments under the New Credit Agreement when due; breach of representations and warranties or covenants under the New Credit Agreement; and invalidity of loan documents.

    The foregoing description of the New Credit Agreement does not purport to be complete and is subject to, and qualified in its entirety by, reference to the New Credit Agreement, a copy of which is attached hereto and filed as Exhibit 10.1 and incorporated herein by reference.

    ITEM 1.02 TERMINATION OF A MATERIAL DEFINITIVE AGREEMENT.

    Please see Item 1.01 above, which information is incorporated by reference into this Item 1.02.

    ITEM 2.03. CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT.

    Please see Item 1.01 above, which information is incorporated by reference into this Item 2.03.



    ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

    (d) Exhibits

    Exhibit NumberDescription
    10.1
    Credit Agreement, dated as of March 5, 2025, by and among Centene Corporation, the lenders from time to time party thereto and Wells Fargo Bank, National Association, as the administrative agent for the lenders.
    104Cover Page Interactive Data File (embedded within the Inline XBRL document).





    SIGNATURE
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    CENTENE CORPORATION
    Date:March 5, 2025By:/s/ ANDREW L. ASHER
    Andrew L. Asher
    Executive Vice President & Chief Financial Officer



    Get the next $CNC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNC

    DatePrice TargetRatingAnalyst
    1/5/2026$54.00Equal Weight → Overweight
    Barclays
    10/14/2025$33.00Sell
    Goldman
    7/28/2025$38.00Overweight → Neutral
    Cantor Fitzgerald
    7/23/2025$30.00Overweight → Equal Weight
    Wells Fargo
    7/21/2025$33.00Buy → Hold
    TD Cowen
    7/16/2025$30.00Neutral → Underperform
    BofA Securities
    7/10/2025$33.00Overweight → Equal-Weight
    Morgan Stanley
    7/2/2025$45.00Buy → Neutral
    UBS
    More analyst ratings

    $CNC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief People Officer Mcnally Tanya M covered exercise/tax liability with 2,785 shares, decreasing direct ownership by 2% to 128,222 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    3/17/26 5:43:53 PM ET
    $CNC
    Medical Specialities
    Health Care

    Chief Operating Officer Smith Susan Raye covered exercise/tax liability with 2,918 shares, decreasing direct ownership by 1% to 212,720 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    3/17/26 5:43:59 PM ET
    $CNC
    Medical Specialities
    Health Care

    Secretary & General Counsel Koster Christopher covered exercise/tax liability with 9,087 shares, decreasing direct ownership by 3% to 352,836 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    3/17/26 5:43:41 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    SEC Filings

    View All

    Centene Corporation filed SEC Form 8-K: Regulation FD Disclosure

    8-K - CENTENE CORP (0001071739) (Filer)

    2/20/26 9:32:27 PM ET
    $CNC
    Medical Specialities
    Health Care

    SEC Form 10-K filed by Centene Corporation

    10-K - CENTENE CORP (0001071739) (Filer)

    2/17/26 4:31:45 PM ET
    $CNC
    Medical Specialities
    Health Care

    Centene Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CENTENE CORP (0001071739) (Filer)

    2/5/26 8:52:22 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $CNC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $CNC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Centene upgraded by Barclays with a new price target

    Barclays upgraded Centene from Equal Weight to Overweight and set a new price target of $54.00

    1/5/26 8:29:16 AM ET
    $CNC
    Medical Specialities
    Health Care

    Goldman initiated coverage on Centene with a new price target

    Goldman initiated coverage of Centene with a rating of Sell and set a new price target of $33.00

    10/14/25 8:47:32 AM ET
    $CNC
    Medical Specialities
    Health Care

    Centene downgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald downgraded Centene from Overweight to Neutral and set a new price target of $38.00

    7/28/25 8:33:52 AM ET
    $CNC
    Medical Specialities
    Health Care

    Chief Executive Officer London Sarah bought $490,365 worth of shares (19,230 units at $25.50), increasing direct ownership by 2% to 845,275 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    8/11/25 5:28:22 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Samuels Theodore R. Ii bought $248,580 worth of shares (9,000 units at $27.62) (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/29/25 6:01:58 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Greco Thomas bought $1,015,750 worth of shares (17,000 units at $59.75), increasing direct ownership by 736% to 19,309 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    12/19/24 5:39:30 PM ET
    $CNC
    Medical Specialities
    Health Care

    WellCare of Kentucky Launches Food Is Medicine Program in Eastern Kentucky to Tackle Growing Diabetes Rates

    Program to support eligible Medicaid enrollees with diabetes in rural Kentucky with tailored initiatives to support nutrition security and chronic disease managementHAZARD, Ky., March 18, 2026 /PRNewswire/ -- WellCare of Kentucky and Centene Foundation, the philanthropic arm of Centene Corporation (NYSE:CNC), today announced an investment of $550,000 to launch the WellCare Food is Medicine Program ("the Program") to address diabetes-related needs in rural communities throughout Eastern Kentucky. The Program builds on an existing nutrition security-related partnership with Mountain Comprehensive Health Corporation (MCHC), a Kentucky-based rural community health center, and Community Agricultu

    3/18/26 2:32:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    Access to Job Training and Community-Based Support Services Improves Through Health Net's $4.4M Investment in LA County

    Investment in NewGen Administrative Services Will Expand Health and Human Services CapacityLOS ANGELES, March 17, 2026 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and a company of Centene Corporation (NYSE:CNC), announced a $4.4 million investment to NewGen Administrative Services LLC to improve a facility that will help people access job training, housing‑related support and community‑based services in Los Angeles County. The investment will support improvements to a Lancaster facility that serves as a key hub for vocation

    3/17/26 10:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    Superior HealthPlan Names Cute Pediatrics as First Rio Grande Valley Provider to Earn Foster Care Distinction

    Superior HealthPlan now has 14 Foster Care Centers of Excellence in Texas HARLINGEN, Texas, March 10, 2026 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a Centene company (NYSE:CNC), has designated Cute Pediatrics as the 14th provider in Texas to be named a Foster Care Center of Excellence. With locations in Brownsville and Harlingen, this is the first provider in the Rio Grande Valley to earn the distinction for providing quality program initiatives that support the foster care community. "Children and youth in foster care de

    3/10/26 1:00:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Centene Corporation

    SC 13G - CENTENE CORP (0001071739) (Subject)

    11/14/24 4:06:01 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/13/24 3:02:23 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/12/24 9:55:15 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Leadership Updates

    Live Leadership Updates

    View All

    eHealth Announces CEO Succession

    Derrick Duke Appointed Chief Executive Officer After Transition Period Fran Soistman to Retire, Remain on eHealth Board of Directors AUSTIN, Texas, July 29, 2025 /PRNewswire/ -- eHealth, Inc. (NASDAQ:EHTH), a leading private online health insurance marketplace (the "Company"), today announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4th 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on t

    7/29/25 9:00:00 AM ET
    $CNC
    $EHTH
    Medical Specialities
    Health Care
    Specialty Insurers
    Finance

    NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

    Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

    5/7/25 2:00:00 PM ET
    $CNC
    $LFST
    Medical Specialities
    Health Care
    Medical/Nursing Services

    CENTENE APPOINTS KENNETH Y. TANJI TO BOARD OF DIRECTORS

    ST. LOUIS, Feb. 24, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, 2025. Mr. Tanji will serve on the Company's Audit and Compliance Committee. The appointment of Mr. Tanji expands Centene's Board of Directors to 12 members. Mr. Tanji's finance acumen spans more than three decades and includes deep knowledge of capital optimization strategies, strategic acquisitions, JV partnership models and the use of advanced analytics and technologies to scale g

    2/24/25 4:15:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Financials

    Live finance-specific insights

    View All

    CENTENE CORPORATION REPORTS 2025 RESULTS AND ANNOUNCES 2026 GUIDANCE

    -- 2025 Full Year GAAP Diluted Loss Per Share of $(13.53); Adjusted Diluted Earnings Per Share of $2.08 -- -- 2026 Adjusted Diluted Earnings Per Share Guidance of Greater than $3.00 -- Consolidated HBR of 94.3% in the fourth quarter of 2025, which includes a Commercial HBR of 95.4% that was 100 basis points higher than expectations driven by net out of period items.Medicaid HBR of 93.0% in the fourth quarter of 2025, reflecting continued progress and representing 40 basis points of sequential improvement compared to the third quarter.Fundamental fourth quarter 2025 trend was consistent with expectations in Medicaid and Medicare Advantage, and slightly favorable in Marketplace and Medicare PD

    2/6/26 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION TO HOST 2025 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS EARNINGS CALL

    ST. LOUIS, Jan. 13, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 fourth quarter and year-end financial results at approximately 6:00 a.m. ET on Friday, February 6, 2026, and host a conference call at 9:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 2815529 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under

    1/13/26 4:30:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION REPORTS THIRD QUARTER 2025 RESULTS

    -- GAAP Diluted Loss Per Share of $(13.50); Adjusted Diluted Earnings Per Share of $0.50 -- Adjusted diluted EPS of $0.50 in the third quarter of 2025, including a $0.10 benefit of a low adjusted effective tax rate in the quarter as compared to the expected full year adjusted effective tax rate of 20-21%.$6.7 billion non-cash goodwill impairment, resulting in a GAAP loss and corresponding reduction of retained earnings in the third quarter of 2025. After the reduction to retained earnings, the debt-to-capital ratio was 45.5% at September 30, 2025.Medicaid HBR of 93.4% in the third quarter, including an approximate 40 basis point benefit from a retroactive revenue adjustment attributed to the

    10/29/25 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care